2013
DOI: 10.3126/jcmc.v3i1.8470
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Status of Furosemide on Liver Cirrhosis with Portal Hypertension and Ascites

Abstract: Cirrhosis of liver is a pathologically defined entity that is associated with a spectrum of characteristic clinical manifesta­tions. Portal hypertension is one of the complication of cirrhosis of liver. We report the case of a 55-year-old man with liver cirrhosis and subsequently portal hypertension and ascites who was admitted to the hospital with headache and indigestion. The patient was treated with furosemide 40 mg OD, lactulose 10 ml HS, Tone, vit K 10 gm IV, Usoliv 300 mg BD and pantoprazole 40 mg OD. Th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…per se In the present study, pretreatment with furosemide (25 and 50 mg/kg) produced significant reductions in acute immobilization or foot-shock stress-induced behavioral alterations in mice. Furosemide is a selective inhibitor of NKCC and is clinically employed in patients with mild to severe congestive heart failure (Francis et al 1985) and portal hypertension (Thapaliya et al 2013) due to its diuretic effect. Apart from the well documented diuretic actions of NKCC blockers, the preclinical studies have also suggested their important role in attenuating cerebral ischemia-induced neuronal injury (Roberts et al 1987), epilepsy (Oriaifo et al 2012), neuropathic pain (Granados-Soto et al 2005), and myocardial infarction (Ternacle et al 2013).…”
Section: Discussionmentioning
confidence: 99%
“…per se In the present study, pretreatment with furosemide (25 and 50 mg/kg) produced significant reductions in acute immobilization or foot-shock stress-induced behavioral alterations in mice. Furosemide is a selective inhibitor of NKCC and is clinically employed in patients with mild to severe congestive heart failure (Francis et al 1985) and portal hypertension (Thapaliya et al 2013) due to its diuretic effect. Apart from the well documented diuretic actions of NKCC blockers, the preclinical studies have also suggested their important role in attenuating cerebral ischemia-induced neuronal injury (Roberts et al 1987), epilepsy (Oriaifo et al 2012), neuropathic pain (Granados-Soto et al 2005), and myocardial infarction (Ternacle et al 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Cirrhosis occurs when the normal structure of the liver is disrupted by bands of scar tissue. One of the normal functions of the liver is to filter blood returning to the heart from the digestive system.In this cirrhosis condition, the presence of scar tissue causes increased resistance to blood flow through the liver, which leads to the development of high pressure in the veins that drain blood into the liver ,resulting in a condition called 'portal hypertension' [3]. Portal hypertension can lead to life-threatening hemorrhage, ascites, and encephalopathy.…”
Section: Introductionmentioning
confidence: 99%